Aether Industries has revised its total revenue potential from the Baker Hughes partnership to INR 750-800 crore. The company is accelerating its Magnum site expansion, with 14 of 16 blocks currently planned. A new agrochemical contract is set to commence production in Q4 FY27, while the semiconductor segment is projected to reach INR 300-400 crore in annual revenue by FY29. Management maintains an aggressive growth strategy focused on complex, high-margin chemistry.
Aether Industries Scales Baker Hughes Partnership and Magnum Site Expansion
Revenue opportunity from Baker Hughes revised to INR 750-800 crore; Magnum site production blocks expanding to 14 of 16.
Reader Takeaway: Strong growth in high-value CEM and CRAMS projects offsets near-term pressure from macro-driven margin volatility.
What just happened
Aether Industries has significantly upgraded its outlook for the Baker Hughes partnership, with total revenue potential now estimated between INR 750-800 crore, doubling previous guidance. The company has officially commenced commercial shipments for its semiconductor segment from existing facilities and secured a new exclusive manufacturing contract for a global agrochemical innovator, which will begin production in Q4 FY27.
Why this matters
The company is pivoting heavily toward its Contract Manufacturing (CEM) and Contract Research and Manufacturing Services (CRAMS) segments, which now contribute over 65% of total sales. By focusing on high-complexity, core-competency chemistry, Aether is scaling its Magnum site, where 14 out of 16 planned production blocks are now in the execution pipeline. This shift is designed to capture higher-value global market shares.
The backstory
The Magnum site serves as the focal point for Aether's future capacity. Management is investing heavily in this facility, with FY27 Capex guidance held at INR 350-370 crore. The firm currently carries INR 700 crore in Capital Work-in-Progress (CWIP), of which INR 400 crore is expected to be capitalized by the end of the fiscal year.
Risks to watch
While management maintains a long-term EBITDA margin goal of over 30%, they have adopted a conservative near-term outlook citing macro-economic volatility and pricing pressures. Additionally, the working capital cycle has seen a minor uptick to 165 days, driven by strategic raw material stockpiling for new site operations.
What to track next
Investors should monitor the scaling of the new agrochemical CEM project, which targets an initial 200-250 tons per year, potentially ramping up to 600 tons. The progress of the dedicated semiconductor block at the Magnum site remains a key catalyst for hitting the targeted FY29 revenue milestone.